(Q35025272)

5 August 2017

title

Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis (English)

1 reference

5 August 2017

1

Giuseppe Minniti

1 reference

5 August 2017

Riccardo Maurizi Enrici

8

object named as

Riccardo Maurizi Enrici

1 reference

5 August 2017

Enrico Clarke

2

1 reference

5 August 2017

Gaetano Lanzetta

3

1 reference

5 August 2017

Mattia Falchetto Osti

4

1 reference

5 August 2017

Guido Trasimeni

5

1 reference

5 August 2017

Alessandro Bozzao

6

1 reference

5 August 2017

Andrea Romano

7

1 reference

5 August 2017

publication date

15 May 2011

1 reference

5 August 2017

1 reference

5 August 2017

volume

6

1 reference

5 August 2017

page(s)

48

1 reference

Creative Commons Attribution 2.0 Generic

5 August 2017

copyright license

start time

15 May 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Randomized phase III trial of platinum-doublet chemotherapy followed by gefitinib compared with continued platinum-doublet chemotherapy in Japanese patients with advanced non-small-cell lung cancer: results of a west Japan thoracic oncology group tr

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Stereotactic radiosurgery in the management of brain metastases: an institutional retrospective analysis of survival.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

CyberKnife radiosurgery in the treatment of complex skull base tumors: analysis of treatment planning parameters

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Stereotactic radiosurgery for multiple brain metastases from breast carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

A multi-institutional analysis of complication outcomes after arteriovenous malformation radiosurgery

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Variables associated with the development of complications from radiosurgery of intracranial tumors.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Radiosurgery and brain tolerance: an analysis of neurodiagnostic imaging changes after gamma knife radiosurgery for arteriovenous malformations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Defining the role of radiosurgery in the management of brain metastases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Factors influencing early complications following Gamma Knife radiosurgery. A prospective study.

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-48

Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-48

Radiosurgery Followed by Planned Observation in Patients with One to Three Brain Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-48

Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-48

Risk analysis of linear accelerator radiosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-48

Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-48

Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-48

Local recurrence of metastatic brain tumor after stereotactic radiosurgery or surgery plus radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-48

Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-48

A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-48

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parall

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-48

Stereotactic radiosurgical treatment of brain metastases in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-48

Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Linear accelerator-based stereotaxic radiosurgery for brain metastases:the influence of number of lesions on survival.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108308

Stereotactic radiosurgery for brain metastases from breast cancer

25 October 2018

1 reference

12 December 2020

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05

1 reference

12 December 2020

Linac stereotactic radiosurgery: an effective and safe treatment for elderly patients with brain metastases

1 reference

12 December 2020

Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397)

1 reference

12 December 2020

Identifiers

DOI

10.1186/1748-717X-6-48

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference